Korea, Republic ofOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 905 out of 116,246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104,484 | 107,495 |
| Total Cites | 14,708 | 16,978 |
| H-index | 54 | 58 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1,172 | 1,347 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 4,326 | 4,873 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,441 | 11,142 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.52 |
| Self-Citation Percentage |
13.37%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,058 out of 109,758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117,553 | 120,049 |
| Total Cites | 13,244 | 15,411 |
| H-index | 51 | 56 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1,094 | 1,266 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 3,870 | 4,382 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,333 | 9,996 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.54 |
| Self-Citation Percentage |
14.06%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,144 out of 101,860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124,591 | 127,349 |
| Total Cites | 10,425 | 12,383 |
| H-index | 47 | 50 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 882 | 1,039 |
| Number of Single+First+Last Authored Papers | 91 | 91 |
| Total Cites to Single+First+Last Authored Papers | 2,990 | 3,458 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,239 | 7,812 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.59 |
| Self-Citation Percentage |
15.81%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,323 out of 84,246 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 139,234 | 142,352 |
| Total Cites | 8,740 | 10,541 |
| H-index | 45 | 47 |
| Hm-index | 19 | 21 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 791 | 945 |
| Number of Single+First+Last Authored Papers | 91 | 91 |
| Total Cites to Single+First+Last Authored Papers | 2,546 | 2,994 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,047 | 6,565 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.61 |
| Self-Citation Percentage |
17.09%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.